Clin2
NCT06881524Possibly a fitNot yet recruiting

Low-dose antibiotic plus licorice and lotus root for H. pylori

HELICOBACTER PYLORI INFECTIONS

Part of Digestive system, Infections clinical trials.

This trial tests a new way to treat H. pylori infection using a low-dose antibiotic combined with natural ingredients (licorice and lotus root powder). It may help clear the infection with fewer side effects than standard treatments.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
374 people
Ages
18 years to 70 years
Study type
Interventional

Who can take part

  • You are between 18 and 70 years old.
  • You have tested positive for H. pylori (a stomach bacteria).
  • You have not taken acid reducers, antibiotics, or bismuth products in the last 4 weeks.
  • You have not had stomach or intestinal surgery.
  • You do not have other serious health conditions like heart, liver, or kidney disease, or cancer.
  • You are not pregnant or breastfeeding, and have not participated in another drug study in the last 3 months.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07750938Not yet recruiting· Phase 4
Better acid control for first-time H. pylori treatment

This study tests a new combination of medicines to treat H. pylori, a stomach infection that can cause ulcers. It aims to see if stronger acid suppression helps the antibiotics work better and clear the infection.

NCT07293910Recruiting· Phase 2
Comparing stomach acid drugs for clearing H. pylori infection

This trial tests different combinations of stomach acid-reducing drugs, vitamin D or probiotics, to see which works best for clearing an H. pylori infection. H. pylori is a common stomach bacteria that can cause ulcers or stomach discomfort.

Shibīn al Kawm
NCT07606833Not yet recruiting· Phase 3
Combination therapy for helicobacter pylori infection

This trial tests a new medication combined with standard antibiotics and bismuth to treat helicobacter pylori, a bacteria that can cause stomach ulcers. It aims to see if this combination is safe and effective in clearing the infection.

Shenzhen, Guangdong
NCT07405684Not yet recruiting· Phase 4
Stool-guided treatment for first-time H. pylori infection

This study compares different first-line antibiotic treatments for H. pylori, a stomach infection that can cause ulcers and other issues. It uses a stool test to choose the best treatment for each person, aiming to improve cure rates and reduce antibiotic resistance.

Shanghai, Shanghai Municipality
NCT07533422Not yet recruiting
Personalized H. pylori rescue treatment using a stool test

This study tests a new way to choose antibiotics for H. pylori infection that didn't go away after first treatment. It uses a stool test to look for antibiotic resistance genes, which may help pick a more effective treatment for you.

NCT06546111Recruiting· Phase 1/Phase 2
Diosmin and hesperidin for H. pylori infection

This trial tests whether a combination of two natural plant compounds, diosmin and hesperidin, can safely and effectively treat Helicobacter pylori (H. pylori) infection in people who have not been treated for it before. The goal is to see if this therapy offers a new option for clearing the bacteria.

Shibīn al Kawm

Hear when a new HELICOBACTER PYLORI INFECTIONS trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.